Lawsuits don’t often end in partnerships. And yet that is the strange but true tale involving Hims & Hers and drug manufacturer Novo Nordisk. Last month, Novo Nordisk sued Hims & Hers over its sale ...

On Thursday, Microsoft joined the running list of tech companies that have rolled out a healthcare-focused chatbot this year. The tech giant is rolling out Copilot Health — a new feature in its ...

Nuclear physics, biotechnology and clinical practice have come a long way, and in the era of AI, these advances are leading to innovative solutions that are truly impacting lives. In the last two ...

Universal Health Services plans to acquire Talkspace for $835 million to create a national behavioral health platform that ...

Six months after withdrawing a drug from the U.S. market for a rare liver disease, Alfasigma is reaffirming its commitment to the disorder by paying $300 million for rights to a GSK drug candidate on ...

In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

New Mexico-based Presbyterian Healthcare Services is scaling its use of GW RhythmX’s AI-powered precision care platform, with 200 of Presbyterian’s primary care clinicians now using the system to help ...

Servier is expanding its cancer drug prospects through the $2.5 billion acquisition of Day One Biopharmaceuticals, a biotech with a commercialized therapy for a type of pediatric glioma and ...

Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business ...

Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and toward pricing linked to the financial impact of their tools. Investors ...